- Review
Psychiatric and neurodevelopmental disorders are prevalent in individuals with epilepsy, adversely affecting quality of life and clinical outcomes through complex, potentially bidirectional mechanisms. This narrative review examines the clinical manifestations, pathophysiology, diagnostic challenges, and therapeutic implications of psychiatric and neurodevelopmental comorbidities in epilepsy. Foundational and contemporary literature addressing mood and anxiety disorders, psychoses, dysphoric syndromes, attention-deficit/hyperactivity disorder (ADHD), autism spectrum disorder (ASD), antiseizure medications, biomarkers, and epilepsy surgery was critically reviewed. Depression and anxiety represent major psychiatric comorbidities, with particularly strong evidence supporting a bidirectional association between depression and epilepsy. Ictal, postictal, and interictal psychiatric manifestations require differentiation from primary psychiatric disorders. ADHD and ASD are also important comorbid neurodevelopmental conditions, presenting overlapping clinical features, shared neurobiological vulnerabilities, and additional diagnostic and therapeutic challenges. Forced normalization and interictal dysphoric disorder remain clinically relevant but incompletely understood. Antiseizure medications may exert beneficial or adverse psychiatric effects, while emerging biomarkers suggest potential shared neurobiological mechanisms that require further validation. Psychiatric comorbidities may influence epilepsy surgery outcomes, and postoperative psychiatric symptoms can occur despite successful seizure control. Comprehensive psychiatric and neurodevelopmental assessment should be integrated throughout epilepsy care, including medication selection, presurgical evaluation, and postoperative follow-up. Individualized, multidisciplinary management is essential to optimize clinical outcomes and improve quality of life.
21 November 2026


